Juliane M. Jürgensmeier
Yale Cancer Center(US)
Publications by Year
Research Areas
Angiogenesis and VEGF in Cancer, Chronic Lymphocytic Leukemia Research, Chronic Myeloid Leukemia Treatments, Lymphoma Diagnosis and Treatment, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Bax directly induces release of cytochrome c from isolated mitochondria(1998)1,518 cited
- → Bax and Adenine Nucleotide Translocator Cooperate in the Mitochondrial Control of Apoptosis(1998)1,170 cited
- → Pro-caspase-3 Is a Major Physiologic Target of Caspase-8(1998)744 cited
- → AZD2171: A Highly Potent, Orally Bioavailable, Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for the Treatment of Cancer(2005)709 cited
- → Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma(2013)590 cited
- → Phase I Clinical Study of AZD2171, an Oral Vascular Endothelial Growth Factor Signaling Inhibitor, in Patients With Advanced Solid Tumors(2007)302 cited
- → Vascular Endothelial Growth Factor Receptors VEGFR-2 and VEGFR-3 Are Localized Primarily to the Vasculature in Human Primary Solid Cancers(2010)236 cited
- → Bax- and Bak-induced cell death in the fission yeast Schizosaccharomyces pombe.(1997)160 cited
- → XIAP-mediated Caspase Inhibition in Hodgkin's Lymphoma–derived B Cells(2003)129 cited
- → Lysosomal membrane permeabilization during apoptosis ‐ involvement of Bax?(2005)122 cited